Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Pao-Chu Chen | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Pao-Chu Chen — Hualien Tzu Chi Hospital
Academic Profile
Researcher Pao-Chu Chen
Affiliation Hualien Tzu Chi Hospital
Country Taiwan
Scopus ID 37081956700
Documents 30
Citations 307
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ResearchGate Profile Link

Pao-Chu Chen is affiliated with Hualien Tzu Chi Hospital in Taiwan and has contributed to clinical medicine research through indexed scientific publications and interdisciplinary healthcare studies. The academic profile demonstrates measurable citation impact and participation in scientific communication systems associated with international biomedical research visibility.[1]

Abstract

This article summarizes the academic profile and scientific contributions of Pao-Chu Chen from Hualien Tzu Chi Hospital, Taiwan. The researcher has contributed to clinical medicine through indexed publications, interdisciplinary healthcare research, and scholarly communication activities. Citation indicators and publication metrics demonstrate measurable academic visibility within international biomedical databases. The profile reflects participation in scientific dissemination, healthcare investigation, and research collaboration associated with clinical medicine and public health advancement. Recognition within the Health Scientists Awards framework highlights scholarly engagement, publication quality, and contribution to evidence-based healthcare research within contemporary academic and clinical environments.[1]

Keywords

  • Clinical Medicine
  • Biomedical Research
  • Health Sciences
  • Healthcare Studies
  • Scopus Author Profile
  • Health Scientists Awards

Introduction

Clinical medicine research contributes to evidence-based healthcare practices, disease management, and interdisciplinary scientific advancement. Researchers engaged in this field support medical knowledge dissemination through peer-reviewed publications, healthcare investigations, and collaborative scientific communication systems within international academic and clinical research environments.[2]

Research Profile

Pao-Chu Chen maintains an academic profile associated with Hualien Tzu Chi Hospital and indexed scientific publications in clinical medicine. Bibliometric indicators demonstrate research visibility through citation activity, scholarly dissemination, and participation in international scientific databases supporting healthcare-related academic communication.[1]

Research Contributions

The researcher has contributed to clinical medicine through healthcare investigations, biomedical publication activities, and scientific collaboration. Research dissemination through indexed journals supports the exchange of validated medical knowledge and strengthens interdisciplinary communication within international healthcare and biomedical research communities.[3]

Publications

The publication record associated with Pao-Chu Chen includes indexed scientific articles contributing to clinical medicine and healthcare research. Peer-reviewed publications support citation visibility, academic dissemination, and integration into international bibliographic databases used for scholarly communication and biomedical knowledge distribution.[1]

Research Impact

Research impact is reflected through publication indexing, citation metrics, and participation in scientific communication systems. The researcher’s academic profile demonstrates measurable scholarly visibility and contribution to healthcare-related scientific literature within internationally recognized biomedical and clinical research databases.[1]

Award Suitability

The academic profile of Pao-Chu Chen aligns with recognition criteria associated with scientific publication activity, citation visibility, and healthcare research contribution. Participation in indexed scholarly communication systems demonstrates engagement with biomedical dissemination practices supporting international academic and clinical research advancement.[4]

Conclusion

Pao-Chu Chen demonstrates sustained involvement in clinical medicine research through indexed publications, citation visibility, and scientific dissemination activities. The academic profile reflects interdisciplinary healthcare engagement and contribution to biomedical scholarship within international research environments supporting evidence-based healthcare communication and scientific advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Pao-Chu Chen, Author ID 37081956700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37081956700
  2. Subramani, K., Su, C.-C., Wang, J.-H., Huang, H.-S., Hsu, C.-S., Chen, P.-C., & Chu, T.-Y. (2025). Tubal ligation exacerbates ovulation-driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin. The Journal of Pathology.
    https://pathsocjournals.onlinelibrary.wiley.com/doi/abs/10.1002/path.70064
  3. Chu, T., Chen, Pao-Chu, Khine, A. A., et al. (2025). Ovulation releases G-CSF to induce peritoneal neutrophil influx and netosis, facilitating peritoneal seeding of high-grade serous carcinoma. Neoplasia.
    https://pubmed.ncbi.nlm.nih.gov/41046768/
  4. Health Scientists Awards. (n.d.). Academic recognition and scientific excellence framework.
    Health Scientists Awards

Eleftherios Papaeleftheriou | Clinical Medicine | Top Clinical Research Award

Published on by Health Scientists

Top Clinical Research Award

Eleftherios Papaeleftheriou
St. Mary’s Hospital Mülheim an der Ruhr, Germany

Eleftherios Papaeleftheriou
Researcher Eleftherios Papaeleftheriou
Affiliation St. Mary’s Hospital Mülheim an der Ruhr
Country Germany
Scopus ID 53881624200
Documents 2
Citations 7
h-index 1
Subject Area Clinical Medicine
Event Health Scientists Awards
Scopus Profile View Profile

The Top Clinical Research Award recognizes the scholarly and clinical research contributions of Eleftherios Papaeleftheriou associated with St. Mary’s Hospital Mülheim an der Ruhr in Germany. The recognition reflects engagement in Clinical Medicine research, scientific communication, and internationally indexed academic dissemination through peer-reviewed publication activity.[1] The award framework acknowledges measurable scholarly participation within clinical and healthcare-oriented research environments supported by internationally recognized academic indexing systems.[2] Additional scholarly infrastructure and citation indexing resources further support international accessibility and publication discoverability.[3]

Abstract

Eleftherios Papaeleftheriou is associated with scholarly activities in Clinical Medicine and healthcare-related research dissemination. Indexed academic contributions reflect participation in peer-reviewed publication systems, citation-based evaluation, and scientific communication relevant to clinical and medical investigation.[1] Research visibility supported through international academic platforms contributes to broader engagement within healthcare and clinical research communities.[3]

Keywords

  • Clinical Medicine
  • Medical Research
  • Scientific Dissemination
  • Clinical Investigation
  • Healthcare Innovation
  • Academic Publications
  • Indexed Research

Introduction

Academic recognition programs in healthcare and biomedical sciences acknowledge scholarly contribution and international scientific communication. The Health Scientists Awards Top Clinical Research Award recognizes researchers engaged in clinical investigation and indexed dissemination.[2] Eleftherios Papaeleftheriou demonstrates scholarly involvement in Clinical Medicine through indexed publications and citation-based evaluation, contributing to academic visibility and engagement within broader medical research communities.[1]

Research Profile

Eleftherios Papaeleftheriou is affiliated with St. Mary’s Hospital Mülheim an der Ruhr in Germany and maintains a scholarly profile indexed through Scopus academic databases.[1] The research profile includes two indexed documents, seven citations, and an h-index value of one, demonstrating participation in scholarly communication and clinical research dissemination. The researcher’s academic activities are associated with Clinical Medicine and healthcare-oriented scientific inquiry, supporting knowledge dissemination within peer-reviewed and internationally accessible research environments.[3]

Research Contributions

The scholarly activities associated with Eleftherios Papaeleftheriou contribute to medical and healthcare-oriented academic communication through indexed publication and citation-based dissemination systems.[1]

  • Participation in clinical and healthcare-related academic research.
  • Contribution to peer-reviewed scientific publication systems.
  • Support for internationally indexed research dissemination.
  • Engagement in citation-based scholarly communication activities.

Publications

Indexed publications associated with Eleftherios Papaeleftheriou contribute to academic visibility and accessibility within international scientific databases. Citation metrics and indexed documentation support evaluation of scholarly dissemination and clinical research engagement.[1]

  1. Peer-reviewed publications associated with Clinical Medicine.
  2. Scientific dissemination through internationally indexed academic databases.
  3. Citation-based contribution to healthcare-related scholarly communication.

Research Impact

Research impact within Clinical Medicine is commonly evaluated through publication visibility, citation activity, and participation in internationally recognized scientific dissemination systems. The indexed academic profile associated with Eleftherios Papaeleftheriou reflects measurable scholarly engagement within healthcare-oriented research environments.[1] Recognition through international academic award frameworks may additionally support interdisciplinary networking, collaborative healthcare investigation, and broader scientific communication opportunities.[2]

Award Suitability

The academic and clinical research profile of Eleftherios Papaeleftheriou reflects characteristics associated with scholarly recognition programs, including indexed publication activity, citation-based visibility, and participation in international scientific dissemination systems.[1] The researcher’s engagement within Clinical Medicine contributes to healthcare-related academic communication and supports continued participation within global scientific and medical research initiatives.[3]

Conclusion

Eleftherios Papaeleftheriou demonstrates scholarly participation within Clinical Medicine through indexed publication activity, scientific dissemination, and engagement in internationally accessible healthcare research systems.[1] Citation indicators and publication visibility collectively support recognition within academic and clinical research communities.[3] The Top Clinical Research Award under the Health Scientists Awards framework represents acknowledgment of scholarly contribution, healthcare-oriented scientific engagement, and participation in international research dissemination initiatives.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Eleftherios Papaeleftheriou, Author ID 53881624200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=53881624200
  2. Health Scientists Awards. (n.d.). International academic recognition and healthcare research award framework.

    https://healthscientists.org/
  3. Sowislok, A., Gruber, G., Kaschani, F., Kaiser, M., Papaeleftheriou, E., & Jäger, M. (2025). Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins. PubMed.

    https://pubmed.ncbi.nlm.nih.gov/41003411/

Dennis De Champeaux | Primary Care | Best Researcher Award

Published on by Health Scientists

Dr. Dennis De Champeaux | Primary Care | Best Researcher Award

University of Amsterdam | United States

Dr. Dennis de Champeaux is a distinguished researcher recognized for his contributions to artificial intelligence, automated reasoning, and computational algorithms. With a Scopus profile reflecting 38 scholarly publications and 236 citations, he has established a measurable research impact, supported by an h-index of 7. His work spans foundational algorithmic development and applied AI systems, including contributions to medical diagnosis algorithms and AI-based assessment frameworks, demonstrating an interdisciplinary approach bridging computer science and healthcare innovation. Notably, his publication on faster linear unification algorithms highlights his expertise in logic programming and symbolic computation. Collaborating with a diverse network of over 35 co-authors, he contributes to advancing intelligent systems and computational efficiency. His research carries societal relevance by supporting improved decision-making in healthcare and enhancing the performance of AI-driven analytical tools, reflecting a commitment to both scientific advancement and real-world applications.

Citation Metrics (Scopus)

236
180
120
60
0

Citations

236

Documents

38

h-index

7

Citations

Documents

h-index

View Scopus Profile
 View ResearchGate Profile

Featured Publications


Medical Diagnosis Algorithm

– Chapter, Feb 2025, Dennis de Champeaux

AI Assessment

– Conference Paper, Feb 2024, Dennis de Champeaux

Hybrid Quicksort for Referenced Items with 1 and 3 Pivots

– Preprint, Jan 2024, Dennis de Champeaux

Hybrid Quicksort for Referenced Items with 1 and 3 pivots

– Preprint, Aug 2023, Dennis de Champeaux

Dutch Flag Algorithm 2.0 for Quicksort

– Preprint, Mar 2023, Dennis de Champeaux

Georg Feigl | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Georg Feigl | Clinical Medicine | Research Excellence Award

Institut für Anatomie und klinische Morphologie, Universität Witten | Germany

Prof. Dr. Georg Christoph Feigl is a Germany-based academic researcher at Universität Witten/Herdecke, specializing in clinical anatomy, surgical education, anesthesiology-related anatomy, and cadaver-based medical training. He has authored over 120 peer-reviewed publications, accumulating 2,419 citations with an h-index of 25, reflecting sustained international impact. His research focuses on anatomical optimization for surgical and interventional procedures, including regional anesthesia, orthopedic and thoracic surgery, and advanced cadaveric models (Thiel and Dodge embalming techniques). Prof. Feigl collaborates widely across disciplines, with 300+ co-authors, contributing to translational studies that bridge anatomy, imaging, and clinical practice. His work supports safer surgical techniques, improved medical training, and evidence-based procedural standards, delivering clear societal benefits through enhanced patient safety, education quality, and clinical outcomes.

Citation Metrics (Scopus)

2419
1800
1200
600
0

Citations

2,419

Documents

120

h-index

25

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Gao Yanjing | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Published on by Health Scientists

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Serhat Gürbüz | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Serhat Gürbüz | Clinical Medicine | Best Researcher Award 

Doctor of Medicine | University of Health Sciences | Turkey

Dr. Serhat Gürbüz, MD, MSc, is a distinguished Consultant in Orthopedics and Traumatology at the Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. His professional expertise centers on knee, shoulder, and sports surgery, integrating advanced arthroscopic techniques and evidence-based rehabilitation strategies to restore function and improve patient outcomes. Dr. Gürbüz has contributed substantially to the field through scholarly publications in reputable peer-reviewed and indexed journals, clinical presentations, and collaborative research projects focused on musculoskeletal disorders and joint preservation. His work demonstrates a commitment to combining clinical excellence with translational research, contributing to the evolution of orthopedic surgical standards and innovations in minimally invasive procedures. He has maintained active collaborations with national and international orthopedic research groups and serves as a peer reviewer and academic contributor within the global orthopedic community. Dr. Gürbüz’s clinical practice reflects a deep dedication to advancing patient-centered care, surgical innovation, and academic mentorship, fostering the development of future orthopedic specialists. His academic engagement and research productivity underscore his contribution to scientific knowledge dissemination and the enhancement of evidence-based orthopedic medicine. Through his multidisciplinary collaborations and continuous pursuit of clinical innovation, Dr. Gürbüz has strengthened the bridge between medical research and practical application, ultimately promoting better musculoskeletal health and improving the quality of life for patients across diverse populations. He has 6 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Çelikoyar, M. M., Topsakal, O., & Gürbüz, S. (2019). Mobile technology for recording surgical procedures. Journal of Visual Communication in Medicine.

2. Imren, Y., Karslioglu, B., Dedeoglu, S. S., Cabuk, H., Atar, S., Gürbüz, S., … (2021). The effect of gluteus maximus tenotomy in primary total hip arthroplasty with posterior approach: Kinematic analysis of hip extensor strength. Journal of Orthopaedic Surgery.

3. Yüce, A., Yerli, M., Erkurt, N., Gürbüz, S., Çakar, M., & Adaş, M. (2022). Neutrophil-lymphocyte and C-reactive protein–albumin ratios as predictors of re-surgery in adult native knee septic arthritis. Journal of Clinical and Investigative Surgery.

4. Gürbüz, S., Bahar, H., Yavuz, U., Keskin, A., Karslioglu, B., & Solak, Y. (2025). Comparative efficacy of ChatGPT and DeepSeek in addressing patient queries on gonarthrosis and total knee arthroplasty. Arthroplasty Today.

5. Gürbüz, S., Ocak, O., Kir, M. C., Karslioglu, B., & Aki, S. (2025). Hyperchloremia at hospital admission for hip fractures is related with an increase in morbidity and mortality rates. Turkish Journal of Trauma and Emergency Surgery.

Dr. Serhat Gürbüz’s work advances global orthopedic science through innovative surgical techniques, evidence-based clinical research, and multidisciplinary collaborations that enhance musculoskeletal health. His commitment to patient-centered innovation and translational research contributes significantly to improving mobility, recovery, and quality of life in society worldwide.